| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018787956 |
| P356 | DOI | 10.1186/S41038-016-0055-7 |
| P932 | PMC publication ID | 4994224 |
| P698 | PubMed publication ID | 27574697 |
| P50 | author | Dorothy M Supp | Q50866878 |
| P2093 | author name string | Jennifer M Hahn | |
| Kelly A Combs | |||
| Kevin L McFarland | |||
| P2860 | cites work | Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies | Q24595036 |
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer | Q26829478 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin | Q28366892 | ||
| Essential roles of Meltrin beta (ADAM19) in heart development | Q28512451 | ||
| TGF-beta-induced epithelial to mesenchymal transition | Q29619820 | ||
| Management of keloids and hypertrophic scars | Q33484869 | ||
| Mechanisms of the epithelial-mesenchymal transition by TGF-beta | Q33804105 | ||
| Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. | Q33816329 | ||
| The Changing Racial and Ethnic Composition of the US Population: Emerging American Identities | Q33901795 | ||
| Keloids: Pathogenesis, Clinical Features, and Management | Q33910210 | ||
| A rapid transient increase in hyaluronan synthase-2 mRNA initiates secretion of hyaluronan by corneal keratocytes in response to transforming growth factor beta | Q34028540 | ||
| Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression | Q34516160 | ||
| Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. | Q38862353 | ||
| Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. | Q39084579 | ||
| Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer | Q39214336 | ||
| IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway | Q39462532 | ||
| Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. | Q39529478 | ||
| A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer | Q40235784 | ||
| Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis | Q40446335 | ||
| Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells | Q40637915 | ||
| Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts | Q40642541 | ||
| Identification and characterization of Wnt signaling pathway in keloid pathogenesis | Q41507378 | ||
| Keloid fibroblasts exhibit an altered response to TGF-beta | Q41595537 | ||
| Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. | Q41898534 | ||
| Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. | Q42031677 | ||
| Wnt signaling controls the phosphorylation status of beta-catenin. | Q42162259 | ||
| RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation | Q42437398 | ||
| Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts | Q43701879 | ||
| Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner | Q44021416 | ||
| Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes | Q45611345 | ||
| Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. | Q46156191 | ||
| SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro | Q46678230 | ||
| Management of keloids in the United States, 1990-2009: an analysis of the National Ambulatory Medical Care Survey | Q46903584 | ||
| SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. | Q50781080 | ||
| Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology. | Q50866794 | ||
| The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. | Q51079695 | ||
| Inhibition of hyaluronan synthase 2 reduces the abnormal migration rate of keloid keratinocytes. | Q51783680 | ||
| Epithelial-mesenchymal transition in keloid tissues and TGF-β1-induced hair follicle outer root sheath keratinocytes. | Q53482048 | ||
| Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis. | Q53556234 | ||
| Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines. | Q53589257 | ||
| Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. | Q54464292 | ||
| Reactive oxygen species stimulates epithelial mesenchymal transition in normal human epidermal keratinocytes via TGF-beta secretion. | Q54506767 | ||
| Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars | Q57892259 | ||
| Antibody to integrin alpha 6 subunit specifically inhibits cell-binding to laminin fragment 8 | Q68416092 | ||
| Alpha 6 integrin distribution in human embryonic and adult tissues | Q72050139 | ||
| Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids | Q78148901 | ||
| Functional implications of the IL-6 signaling pathway in keloid pathogenesis | Q79196272 | ||
| Epithelial-mesenchymal interactions in pulmonary fibrosis | Q82331355 | ||
| The role of R-spondin2 in keratinocyte proliferation and epidermal thickening in keloid scarring | Q82901140 | ||
| Methods for the Serum-Free Culture of Keratinocytes and Transplantation of Collagen-GAG-Based Skin Substitutes | Q83520479 | ||
| The structure of the basement membrane zone differs between keloids, hypertrophic scars and normal skin: a possible background to an impaired function | Q87411873 | ||
| A systems view of epithelial-mesenchymal transition signaling states | Q34579646 | ||
| Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma | Q34644985 | ||
| Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders | Q34750464 | ||
| Wnt5a as an effector of TGFβ in mammary development and cancer | Q35022625 | ||
| The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis | Q35112866 | ||
| Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA | Q35201461 | ||
| Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin | Q35719092 | ||
| Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition | Q35790264 | ||
| Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells | Q35827597 | ||
| Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta | Q36232185 | ||
| Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator | Q36255285 | ||
| Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management | Q36568277 | ||
| Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer | Q36840255 | ||
| Levels of evidence for the treatment of keloid disease | Q36888451 | ||
| Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar | Q36922420 | ||
| Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression | Q37044614 | ||
| Cadherin switching | Q37102948 | ||
| The relevance of the TGF-β Paradox to EMT-MET programs | Q37118399 | ||
| Current progress in keloid research and treatment | Q37128010 | ||
| Laminin-332 and -511 in skin. | Q37161422 | ||
| Biomarkers for epithelial-mesenchymal transitions | Q37209254 | ||
| Postburn scars: an update | Q37256100 | ||
| Breaching the basement membrane: who, when and how? | Q37291643 | ||
| Cadherin-6B is proteolytically processed during epithelial-to-mesenchymal transitions of the cranial neural crest | Q37416517 | ||
| Keloids: current concepts of pathogenesis (review). | Q37565115 | ||
| Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition | Q37583186 | ||
| Molecular dissection of abnormal wound healing processes resulting in keloid disease. | Q37651177 | ||
| Inflammation and EMT: an alliance towards organ fibrosis and cancer progression | Q37668231 | ||
| The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. | Q37760963 | ||
| The role of the epidermis and the mechanism of action of occlusive dressings in scarring | Q37906763 | ||
| The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example | Q37955061 | ||
| TGFβ and matrix-regulated epithelial to mesenchymal transition | Q38190340 | ||
| Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis | Q38238365 | ||
| Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. | Q38367022 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | keratinocyte | Q1473931 |
| P304 | page(s) | 30 | |
| P577 | publication date | 2016-08-23 | |
| P1433 | published in | Burns & trauma | Q27726275 |
| P1476 | title | Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1 | |
| P478 | volume | 4 |
| Q49379707 | Aberrantly expressed long noncoding RNAs in hypertrophic scar fibroblasts in vitro: A microarray study. |
| Q58115265 | Adipose-derived mesenchymal stem cells treatments for fibroblasts of fibrotic scar via downregulating TGF-β1 and Notch-1 expression enhanced by photobiomodulation therapy |
| Q91938162 | Animal Models for Studies of Keloid Scarring |
| Q94673354 | Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes |
| Q90384169 | Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial-Mesenchymal Transition |
| Q33742115 | Role of the microRNA-29 family in fibrotic skin diseases. |
| Q96304791 | The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models |
| Q52718681 | Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells. |
| Q92800229 | Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies |
Search more.